• Publications
  • Influence
An update on progress and the changing epidemiology of causes of childhood blindness worldwide.
PURPOSE To summarize the available data on pediatric blinding disease worldwide and to present current information on childhood blindness in the United States. METHODS A systematic search of worldExpand
  • 203
  • 5
Scleral-fixated capsular tension rings and segments for ectopia lentis in children.
PURPOSE To report the short-term outcomes and complications of implantation of scleral-fixated capsular tension rings and/or capsular tension segments with intraocular lenses (IOL) in pediatricExpand
  • 19
  • 4
Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity.
PURPOSE To measure serum levels of bevacizumab and to compare serum levels of free vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF-1) in infants who were treated withExpand
  • 69
  • 1
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study
Importance Intravitreous bevacizumab (0.25 to 0.625 mg) is increasingly used to treat type 1 retinopathy of prematurity (ROP), but there remain concerns about systemic toxicity. A much lower dose mayExpand
  • 48
  • 1
Long-Term Outcomes of Iris-sutured Posterior Chamber Intraocular Lenses in Children.
PURPOSE To report the long-term outcomes and complications of iris-sutured posterior chamber intraocular lenses (PCIOLs) in the pediatric population. DESIGN Retrospective interventional case study.Expand
  • 8
  • 1
Evaluating the association of autonomic drug use to the development and severity of retinopathy of prematurity.
PURPOSE To explore the association of autonomic agents with the development and severity of retinopathy of prematurity (ROP). METHODS The medical records of all preterm infants screened for ROPExpand
  • 7
  • 1
Evaluation of structural contributors in myopic eyes of preterm and full-term children
PurposeWe conducted a cross-sectional study to test the hypothesis that the structural contributions to myopia in preterm and full-term born children are different.MethodsIn this study, 93 childrenExpand
  • 4
  • 1
Colorado retinopathy of prematurity model: a multi-institutional validation study.
PURPOSE The Colorado retinopathy of prematurity (ROP) prediction model (CO-ROP), developed using a cohort of infants from Colorado, calls for ROP examination of infants meeting all of the followingExpand
  • 15
A Dosing Study of Bevacizumab for Retinopathy of Prematurity: Late Recurrences and Additional Treatments.
PURPOSE Intravitreal bevacizumab is increasingly used to treat severe retinopathy of prematurity (ROP), but it enters the bloodstream, and there is concern that it may alter development of otherExpand
  • 15